EP3292206
GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.5.2016EP published:
22.12.2021EP application number:
16724546.3
EPO information:
European Patent Register
Max expiry date:
5.5.2036
Title in English:
GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASELanguage of the patent:
English
Timeline
Today
6.5.2016EP application
22.12.2021EP Publication
Owner
Name:
Shire Human Genetic Therapies, Inc.Address:
300 Shire Way, Lexington, MA 02421, US
Name:
The McLean Hospital CorporationAddress:
115 Mill Street, Belmont, MA 02478, US
Inventor
Name:
PARK, Yung HeeAddress:
Lexington, MA 02421, US
Name:
ISACSON, OleAddress:
Belmont, MA 02478, US
Priority
Number:
201562158244 PDate:
7.5.2015Country:
US
Classification
Categories:
C12N 15/864, A61K 38/47, A61K 48/00, A61K 35/76, A61P 25/16, C12N 9/24